BCR-ABL1 fusion gene, the hallmark of CML resulted from t(9;22), is also present in 25% of adults ALL and 2–4% of childhood ALL. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.